blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3950954

EP3950954 - METHOD FOR DETERMINING PROGNOSIS OF ENDOMETRIAL CANCER [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  17.11.2023
Database last updated on 02.07.2024
FormerRequest for examination was made
Status updated on  07.01.2022
FormerThe international publication has been made
Status updated on  13.06.2020
Most recent event   Tooltip17.11.2023Withdrawal of applicationpublished on 20.12.2023  [2023/51]
Applicant(s)For all designated states
Keio University
15-45, Mita 2-chome
Minato-ku
Tokyo, 108-8345 / JP
For all designated states
Sekisui Medical Co., Ltd.
1-3, Nihonbashi 2-chome
Chuo-ku
Tokyo 103-0027 / JP
[2022/06]
Inventor(s)01 / KANAI, Yae
c/o School of Medicine, Keio University
35, Shinanomachi, Shinjuku-ku
Tokyo 160-8582 / JP
02 / ARAI, Eri
c/o School of Medicine, Keio University
35, Shinanomachi, Shinjuku-ku
Tokyo 160-8582 / JP
03 / AOKI, Daisuke
c/o School of Medicine, Keio University
35, Shinanomachi, Shinjuku-ku
Tokyo 160-8582 / JP
04 / SUSUMU, Nobuyuki
c/o School of Medicine, Keio University
35, Shinanomachi, Shinjuku-ku
Tokyo 160-8582 / JP
05 / YAMAGAMI, Wataru
c/o School of Medicine, Keio University
35, Shinanomachi, Shinjuku-ku
Tokyo 160-8582 / JP
06 / MAKABE, Takeshi
c/o School of Medicine, Keio University
35, Shinanomachi, Shinjuku-ku
Tokyo 160-8582 / JP
[N/P]
Former [2022/06]01 / KANAI, Yae
Tokyo 160-8582 / JP
02 / ARAI, Eri
Tokyo 160-8582 / JP
03 / AOKI, Daisuke
Tokyo 160-8582 / JP
04 / SUSUMU, Nobuyuki
Tokyo 160-8582 / JP
05 / YAMAGAMI, Wataru
Tokyo 160-8582 / JP
06 / MAKABE, Takeshi
Tokyo 160-8582 / JP
Representative(s)Blodig, Wolfgang
Wächtershäuser & Hartz
Patentanwaltspartnerschaft mbB
Weinstrasse 8
80333 München / DE
[N/P]
Former [2022/06]Schiener, Jens
Wächtershäuser & Hartz
Patentanwaltspartnerschaft mbB
Weinstraße 8
80333 München / DE
Application number, filing date19894068.605.12.2019
[2022/06]
WO2019JP47656
Priority number, dateJP2018022827605.12.2018         Original published format: JP 2018228276
[2022/06]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020116573
Date:11.06.2020
Language:JA
[2020/24]
Type: A1 Application with search report 
No.:EP3950954
Date:09.02.2022
Language:EN
[2022/06]
Search report(s)International search report - published on:JP11.06.2020
(Supplementary) European search report - dispatched on:EP25.07.2022
ClassificationIPC:C12Q1/04, C12Q1/68, C12Q1/6886, G01N33/50
[2022/06]
CPC:
C12Q1/6886 (EP,US); C12Q2500/00 (US); C12Q2600/106 (EP);
C12Q2600/118 (EP); C12Q2600/154 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/06]
TitleGerman:VERFAHREN ZUR BESTIMMUNG DER PROGNOSE VON ENDOMETRIUMKARZINOM[2022/06]
English:METHOD FOR DETERMINING PROGNOSIS OF ENDOMETRIAL CANCER[2022/06]
French:MÉTHODE POUR DÉTERMINER LE PRONOSTIC D'UN CANCER DE L'ENDOMÈTRE[2022/06]
Entry into regional phase28.05.2021Translation filed 
28.05.2021National basic fee paid 
28.05.2021Search fee paid 
28.05.2021Designation fee(s) paid 
28.05.2021Examination fee paid 
Examination procedure28.05.2021Examination requested  [2022/06]
17.02.2023Amendment by applicant (claims and/or description)
10.11.2023Application withdrawn by applicant  [2023/51]
Fees paidRenewal fee
31.12.2021Renewal fee patent year 03
29.12.2022Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2013033627  (UNIV CALIFORNIA [US], et al) [X] 9-12 * GS_NUC_ALERT:WO2013033627.47388 *;
 [X]  - NICOLAS WENTZENSEN ET AL, "Discovery and validation of methylation markers for endometrial cancer", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, US, (20140331), vol. 135, no. 8, doi:10.1002/IJC.28843, ISSN 0020-7136, pages 1860 - 1868, XP071288171 [X] 1,3 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.28843
 [I]  - MAKABE T ET AL, "Genome-wide DNA methylation analysis in young-onset endometrial cancer", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20180901), Database accession no. EMB-624278171, XP002807032 [I] 2,4-8 * abstract *
    [ ] - INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 20180901 LIPPINCOTT WILLIAMS AND WILKINS NLD, (20180901), vol. 28, no. Supplement 2, ISSN 1525-1438, pages 79 CONF 20180914 to 20180916 Kyoto - 17th Bien
 [I]  - MAKABE T, "Genome-wide DNA methylation profile of young-onset endometrial cancer", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20181201), Database accession no. EMB-626626571, XP002807033 [I] 2,4-8 * abstract *
    [ ] - CANCER SCIENCE 20181201 BLACKWELL PUBLISHING LTD NLD, (20181201), vol. 109, no. Supplement 2, ISSN 1349-7006, pages 1304 CONF 20180927 to 20180929 Osaka - 77th Annu
 [T]  - TAKESHI MAKABE ET AL, "Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer", CARCINOGENESIS, GB, (20190309), vol. 40, no. 5, doi:10.1093/carcin/bgz046, ISSN 0143-3334, pages 611 - 623, XP055717970

DOI:   http://dx.doi.org/10.1093/carcin/bgz046
International search[XA]US2008254470  (BERLIN KURT [DE]) [X] 1-3, 7-9 * claims 1-2, 9, paragraphs [0057], [0061], [0147], [0247] * [A] 4-6, 10-12;
 [X]JP2011160711  (KEIO GIJUKU) [X] 1-12 * claim 2, paragraphs [0005], [0025], [0036], [0047], table 1 *;
 [XA]JP2015526096  (NATIONAL DEFENSE MEDICAL CENTER) [X] 1-3, 7-9 * claim 38, paragraph [0014], table 1 * [A] 4-6, 10-12;
 [X]  - Makabe, Takeshi; Arai, Eri; Hirasawa, Akira; Yamagami, Wataru; Susumu, Nobuyuki; Aoki, Daisuke; Kanai, Yae, "P-3079: Genome-wide DNA methylation profile of juvenile endometrial cancer", Abstracts of the 77th Annual Academic General Conference of the Japanese Cancer Association; September 27-29, 2018, JP, (20180929), vol. 77, page 1304, XP009527944 [X] 1-12
 [X]  - Makabe T, "Genetic and epigenetic characterization of young-onset endometrial cancer", Journal of Japan Society of Obstetrics and Gynecology, (20180201), vol. 70, no. 2, ISSN 0300-9165, page 526, XP009527871 [X] 1-12
 [PX]  - Takeshi Makabe, Arai Eri, Hirano Takuro, Ito Nanako, Fukamachi Yukihiro, Takahashi Yoriko, Hirasawa Akira, Yamagami Wataru, Susumu Nobuyuki, Aoki Daisuke, Kanai Yae, "Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer", Carcinogenesis, (20190309), vol. 40, no. 5, doi:10.1093/carcin/bgz046, ISSN 0143-3334, pages 611 - 623, XP055717970 [PX] 1-12 * , abstract, fig. 5 *

DOI:   http://dx.doi.org/10.1093/carcin/bgz046
by applicantWO2012108516
 WO2013168644
 WO2015129916
    - J. Gynecol. Oncol., (20180000), vol. 29, page e21
    - PLoS One, (20170000), vol. 12, page e0173242
    - Epigenetics, (20170000), vol. 12, pages 19 - 26
    - BMC Genomics, (20140000), vol. 15, page 868
    - Epigenetics, (20130000), vol. 8, pages 1355 - 72
    - CLARK SJ et al., Nucleic Acids Res., (19940000), vol. 22, pages 2990 - 7
    - JURINKE C et al., Mutat. Res., (20050000), vol. 573, pages 83 - 95
    - Anal. Biochem., (20000000), vol. 10, pages 103 - 110
    - WOJDACZ TK et al., Nat. Protoc., (20080000), vol. 3, pages 1903 - 8
    - KRISTENSEN LS et al., Clin. Chem., (20090000), vol. 55, pages 1471 - 83
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.